BrightSpring Q1 revenue up 26% to $3.6B; raises FY 2026 EBITDA guidance to $795M-$825M

BrightSpring Health Services, Inc.

2026-Q1 EPS reported $0.67 revenue$3,613,721,000

Net income $74M vs $9M a year ago; Adjusted EBITDA $190M, up 45% YoY from $131M.
Pharmacy Solutions revenue $3,171M (+25%), Provider Services revenue $442M (+28%).
Community Living divestiture closed March 30; $31.2M gain on sale recorded in discontinued ops.
FY 2026 guidance raised: Revenue $14.7B-$15.2B (14-18% growth), EBITDA $795M-$825M (29-34% growth).
Leverage improved to 2.27x from pro forma 2.60x at year-end 2025.

item 2.02item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.